Prelude Capital Management’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-2,700
Closed -$716K – 1320
2022
Q4
$716K Buy
+2,700
New +$658K 0.04% 454
2022
Q3
– Sell
-3,600
Closed -$723K – 1744
2022
Q2
$723K Sell
3,600
-900
-20% -$211K 0.02% 646
2022
Q1
$1.36M Buy
4,500
+3,000
+200% +$876K 0.04% 479
2021
Q4
$539K Buy
+1,500
New +$516K 0.01% 960
2016
Q2
– Sell
-3,600
Closed -$240K – 1646
2016
Q1
$240K Buy
+3,600
New +$223K 0.03% 490
2014
Q2
– Sell
-41,400
Closed -$2.02M – 2044
2014
Q1
$2.02M Buy
+41,400
New +$1.95M 0.27% 63

Other funds holding ISRG

Prelude Capital Management's ISRG Position: Q2 2026 in Review

Prelude Capital Management sold out of Intuitive Surgical (ISRG) in Q2 2026, closing a stake of 2,661 shares — an estimated $1.23M sold.

Prelude Capital Management first reported a position in ISRG in Q3 2013 and held it in 35 quarters. The position peaked at $1.99M in Q1 2022. 2,258 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Prelude Capital Management reported no remaining Intuitive Surgical position as of Q2 2026 after selling out during the quarter.
  • Prelude Capital Management sold 2,661 Intuitive Surgical shares in Q2 2026, an estimated $1.23M.
  • Prelude Capital Management first reported a position in Intuitive Surgical in Q3 2013 and held it in 35 quarters.
  • Prelude Capital Management's Intuitive Surgical position peaked at $1.99M in Q1 2022.
  • 2,258 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.